Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

Moderna-Merck melanoma therapy averts cancer recurrence in study

Posted on August 19, 2026
By Chicago Tribune
0 Views
1 min read

In brief

Generating AI summary…

Moderna-Merck melanoma therapy averts cancer recurrence in study

A personalized vaccine developed by Moderna Inc. and Merck & Co. helped reduce the recurrence of melanoma in a large, late-stage trial, raising expectations for a potential life-extending treatment for an insidious form of cancer.